Literature DB >> 29571271

Subgroup effects of occupational therapy-based intervention for people with advanced cancer.

Marc Sampedro Pilegaard1,2, Lisa Gregersen Oestergaard3,4, Karen la Cour1,2, Anna Thit Johnsen5,6, Åse Brandt2,7.   

Abstract

Background: Many people with advanced cancer have decreased ability to perform activities of daily living (ADL). We recently performed a randomized, controlled trial (RCT) assessing the efficacy of an occupational therapy-based program, the 'Cancer Home-Life Intervention' in people with advanced cancer (N = 242) and found no overall effects on ADL ability. However, heterogeneity of treatment effect may disguise subgroup differences.Objective: To investigate whether subgroups of people with advanced cancer gain positive effects from the 'Cancer Home-Life Intervention' on ADL ability.Material and method: An exploratory subgroup analysis including 191 participants from a RCT. The outcome was ADL motor ability measured by the Assessment of Motor and Process Skills (AMPS). Subgroups were defined by age, gender, years of education, type of primary tumor, functional level, and activity problems.
Results: The 'Cancer Home-Life Intervention' had no statistically significant effect in the six subgroups. Modifying effects of age (0.30 [95% CI: -0.05 to 0.64]) and gender (0.23 [95% CI: -0.11 to 0.57]) were not found.
Conclusion: There were no subgroup effects of the 'Cancer Home-Life Intervention'on ADL motor ability. Some indications suggest greater effects for those aged below 69 years; however, this result should be interpreted with caution.

Entities:  

Keywords:  Activities of daily living; moderator variables; neoplasms; occupational therapy; randomized controlled trial

Mesh:

Year:  2018        PMID: 29571271     DOI: 10.1080/11038128.2018.1455897

Source DB:  PubMed          Journal:  Scand J Occup Ther        ISSN: 1103-8128            Impact factor:   2.611


  1 in total

1.  A resource-oriented intervention addressing balance in everyday activities and quality of life in people with advanced cancer: protocol for a feasibility study.

Authors:  Marc Sampedro Pilegaard; Helle Timm; Heidi Klit Birkemose; Sandra Bakkegaard Dupont; Dorthe Soested Joergensen; Karen la Cour
Journal:  Pilot Feasibility Stud       Date:  2022-04-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.